Exelixis, Inc. (EXEL) DCF Valuation

Exelixis, Inc. (EXEL) DCF Valuation
  • ✓ Completamente Editable: Adáptelo A Sus Necesidades En Excel O Sheets
  • ✓ Diseño Profesional: Plantillas Confiables Y Estándares De La Industria
  • ✓ Predeterminadas Para Un Uso Rápido Y Eficiente
  • ✓ No Se Necesita Experiencia; Fáciles De Seguir

Exelixis, Inc. (EXEL) Bundle

DCF model
Get Full Bundle:
$25 $15
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7
$12 $7

TOTAL:

Simplify Exelixis, Inc. (EXEL) valuation with this customizable DCF Calculator! Featuring real Exelixis, Inc. (EXEL) financials and adjustable forecast inputs, you can test scenarios and uncover Exelixis, Inc. (EXEL) fair value in minutes.


Discounted Cash Flow (DCF) - (USD MM)

Year AY1
2019		 AY2
2020		 AY3
2021		 AY4
2022		 AY5
2023		 FY1
2024		 FY2
2025		 FY3
2026		 FY4
2027		 FY5
2028
Revenue 967.8 987.5 1,435.0 1,611.1 1,830.2 1,994.3 2,173.0 2,367.8 2,580.0 2,811.3
Revenue Growth, % 0 2.04 45.31 12.27 13.6 8.96 8.96 8.96 8.96 8.96
EBITDA 369.5 110.1 300.3 222.4 196.6 378.1 412.0 448.9 489.1 533.0
EBITDA, % 38.18 11.14 20.93 13.8 10.74 18.96 18.96 18.96 18.96 18.96
Depreciation 11.2 14.0 13.6 20.9 25.7 24.8 27.0 29.5 32.1 35.0
Depreciation, % 1.15 1.41 0.94985 1.3 1.41 1.24 1.24 1.24 1.24 1.24
EBIT 358.3 96.1 286.7 201.5 170.9 353.3 384.9 419.4 457.0 498.0
EBIT, % 37.02 9.73 19.98 12.51 9.34 17.71 17.71 17.71 17.71 17.71
Total Cash 852.2 1,206.5 1,467.1 1,308.5 995.3 1,689.8 1,841.2 2,006.3 2,186.1 2,382.1
Total Cash, percent .0 .0 .0 .0 .0 .0 .0 .0 .0 .0
Account Receivables 119.1 160.9 282.7 214.8 237.4
Account Receivables, % 12.3 16.29 19.7 13.33 12.97
Inventories 12.9 21.0 27.5 33.3 17.3 33.4 36.4 39.7 43.3 47.1
Inventories, % 1.33 2.12 1.92 2.07 0.9465 1.68 1.68 1.68 1.68 1.68
Accounts Payable 11.6 23.6 24.3 32.7 33.8 36.5 39.8 43.3 47.2 51.5
Accounts Payable, % 1.2 2.39 1.69 2.03 1.85 1.83 1.83 1.83 1.83 1.83
Capital Expenditure -12.8 -30.3 -64.2 -138.5 -163.0 -105.2 -114.6 -124.9 -136.1 -148.3
Capital Expenditure, % -1.33 -3.07 -4.48 -8.59 -8.9 -5.27 -5.27 -5.27 -5.27 -5.27
Tax Rate, % 19.32 19.32 19.32 19.32 19.32 19.32 19.32 19.32 19.32 19.32
EBITAT 288.9 82.1 225.2 156.7 137.9 284.8 310.3 338.1 368.5 401.5
Depreciation
Changes in Account Receivables
Changes in Inventories
Changes in Accounts Payable
Capital Expenditure
UFCF 166.9 27.9 46.9 109.6 -4.9 130.9 196.3 213.9 233.1 254.0
WACC, % 6.81 6.81 6.8 6.8 6.81 6.81 6.81 6.81 6.81 6.81
PV UFCF
SUM PV UFCF 832.2
Long Term Growth Rate, % 4.00
Free cash flow (T + 1) 264
Terminal Value 9,416
Present Terminal Value 6,775
Enterprise Value 7,607
Net Debt -73
Equity Value 7,680
Diluted Shares Outstanding, MM 321
Equity Value Per Share 23.89

What You Will Get

  • Editable Forecast Inputs: Easily modify assumptions (growth %, margins, WACC) to explore various scenarios.
  • Real-World Data: Exelixis, Inc. (EXEL) financial data pre-loaded to enhance your analysis.
  • Automatic DCF Outputs: The template computes Net Present Value (NPV) and intrinsic value automatically.
  • Customizable and Professional: A refined Excel model tailored to meet your valuation requirements.
  • Built for Analysts and Investors: Perfect for evaluating projections, confirming strategies, and increasing efficiency.

Key Features

  • Comprehensive DCF Calculator: Features detailed unlevered and levered DCF valuation models tailored for Exelixis, Inc. (EXEL).
  • WACC Calculator: Pre-configured Weighted Average Cost of Capital sheet with adjustable inputs specific to Exelixis, Inc. (EXEL).
  • Customizable Forecast Assumptions: Adjust growth rates, capital expenditures, and discount rates to reflect Exelixis, Inc. (EXEL) projections.
  • Integrated Financial Ratios: Evaluate profitability, leverage, and efficiency ratios relevant to Exelixis, Inc. (EXEL).
  • Interactive Dashboard and Charts: Visual representations summarize essential valuation metrics for streamlined analysis of Exelixis, Inc. (EXEL).

How It Works

  1. Step 1: Download the Excel file.
  2. Step 2: Review Exelixis, Inc.'s (EXEL) pre-filled financial data and forecasts.
  3. Step 3: Modify critical inputs such as revenue growth, WACC, and tax rates (highlighted cells).
  4. Step 4: Watch the DCF model update instantly as you tweak assumptions.
  5. Step 5: Analyze the outputs and use the results for investment decisions.

Why Choose This Calculator for Exelixis, Inc. (EXEL)?

  • Accuracy: Utilizes real Exelixis financials to ensure precise data.
  • Flexibility: Tailored for users to easily adjust and test various inputs.
  • Time-Saving: Avoid the complexities of constructing a DCF model from the ground up.
  • Professional-Grade: Crafted with the precision and usability expected at the CFO level.
  • User-Friendly: Intuitive interface, suitable for users without extensive financial modeling skills.

Who Should Use This Product?

  • Individual Investors: Make informed decisions about buying or selling Exelixis, Inc. (EXEL) stock.
  • Financial Analysts: Streamline valuation processes with ready-to-use financial models for Exelixis, Inc. (EXEL).
  • Consultants: Deliver professional valuation insights on Exelixis, Inc. (EXEL) to clients quickly and accurately.
  • Business Owners: Understand how biotech companies like Exelixis, Inc. (EXEL) are valued to guide your own strategy.
  • Finance Students: Learn valuation techniques using real-world data and scenarios related to Exelixis, Inc. (EXEL).

What the Template Contains

  • Operating and Balance Sheet Data: Pre-filled Exelixis, Inc. (EXEL) historical data and forecasts, including revenue, EBITDA, EBIT, and capital expenditures.
  • WACC Calculation: A dedicated sheet for Weighted Average Cost of Capital (WACC), including parameters like Beta, risk-free rate, and share price.
  • DCF Valuation (Unlevered and Levered): Editable Discounted Cash Flow models showing intrinsic value with detailed calculations.
  • Financial Statements: Pre-loaded financial statements (annual and quarterly) to support analysis.
  • Key Ratios: Includes profitability, leverage, and efficiency ratios for Exelixis, Inc. (EXEL).
  • Dashboard and Charts: Visual summary of valuation outputs and assumptions to analyze results easily.

No products were found matching.